Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Nanoparticles that exhibit high epithelial uptake and transepithelial transport More
precise and focused control of temperature mediated therapy and “triggering” deliverables in situ. More
Novel agents capable of reaching remote cellular sites More
High concentrated liquid Omega 3 for infants More
Novel micelles by creating amphiphilic block copolymers... More
MRI contast medium More
drug delivery - a novel and effective method for the microencapsulation of small peptides that allows their use and controlled release over a time frame of several months. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms More
Related Reports
Market Research Reports provided by reports.innovaro.com
Jun 2008 - 175 pages - $3,835
Jan 2011 - 124 pages - $1,740
Oct 2010 - 97 pages - $3,835
Jun 2009 - 472 pages - $3,140
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Nov 2010 - 97 pages - $600
Dec 2009 - 84 pages - $7,600
Nov 2010 - 428 pages - $2,695
Your selection
Browse By
- Industry sector
- Intravesical
- Nasal
- Nasal topical
- Ophthalmic
- Oral liquid
- Oral solid
- Otic
- Parenteral
- Pulmonary
- Rectal
- Systemic
- Topical
- Vaginal
- Therapeutic target
- Ayuverdic medicine
- Chinese medicine
- Dietetic
- Homeopathy
- Iron excess
- Kanpo medicine
- Other
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us